Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase IIa Trial Evaluating the Safety and Efficacy of a New Centrally Acting Analgesic in Subjects With Pain Due to Diabetic Polyneuropathy

NCT00878293 is registered in ClinicalTrials.gov with Tris Pharma, Inc. as lead sponsor.

NCT NCT00878293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00878293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase IIa Trial Evaluating the Safety and Efficacy of a New Centrally Acting Analgesic in Subjects With Pain Due to Diabetic Polyneuropathy
Lead sponsor
Tris Pharma, Inc.
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2009
Completion date
May 31, 2010
Enrollment
90 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic polyneuropathy